Auditory Global-Local Processing in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis.

J Autism Dev DisordJun 24, 2025 (epub)
Clinical ResearchPsychiatryNeurologyPediatricsOpen access

Min Zhu, Fei Chen, Yu Zhang et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis examined auditory global-local pitch processing in individuals with autism spectrum disorder (ASD) compared with typically developing peers. A search of four databases identified 25 studies for quantitative synthesis. The pooled effect for global pitch processing was not statistically significant (Hedges' g = -0.05), while local pitch processing showed a significant, modest effect (Hedges' g = 0.29). The authors report that task and participant factors, including vocabulary size, may help explain variation across studies. Overall, the findings suggest a tendency toward local processing without evidence of a global-processing deficit.

Key findings

  • Global pitch processing showed no statistically significant pooled difference (Hedges' g = -0.05).
  • Local pitch processing showed a significant, modest pooled effect (Hedges' g = 0.29).
  • Global-processing results varied with answer-choice number, language typology, and participants' vocabulary size.
  • Vocabulary size among autistic participants and task paradigm differences were associated with variation in local-processing outcomes.

Why it matters

The findings distinguish a possible local-processing preference from a broad impairment in global auditory processing. This may help clinicians and researchers interpret auditory task performance in ASD without assuming that global processing is uniformly deficient. The identified moderators also underscore that task design and participant characteristics can influence observed results.

What to keep in mind

The synthesis included only 25 studies, and the abstract reports heterogeneity in findings related to task paradigms and participant characteristics.

Source

Published in J Autism Dev Disord. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.